News and Trends 6 Mar 2025 Top biotech deals of February 2025 …$2.15 billion in milestone payments, with Novartis having paid $925 million upfront. Anthos will hand over its monoclonal antibody program, which is in the clinic to prevent stroke and systemic… March 6, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 26 Oct 2016 Can this new Antibody-Drug Conjugate Collaboration make it to the Top? Nordic Nanovector is collaborating with Heidelberg Pharma to access the promising antibody-drug conjugate (ADC) technology. However, can it really take on the strong competition? Nordic Nanovector develops antibody-radionuclide conjugates (ARCs)… October 26, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 8 Aug 2025 Top biotech deals in July 2025 …will secure LaNova’s lead candidate, an antibody-drug conjugate (ADC) called LM-302, which is in the clinic to treat gastric cancer and pancreatic ductal adenocarcinoma – the most common type of… August 8, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 2 Nov 2017 Swiss Biotech Gets €12M as its Alzheimer’s Candidate Enters Phase II …antibody’s efficacy and safety. AC Immune’s anti-Tau monoclonal antibody is based on the company’s SupraAntigen technology. They are generated by injecting the SupraAntigen constructs into mice and selecting antibodies that… November 2, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 4 Feb 2025 World Cancer Day: trends in cancer therapeutics to look forward to in 2025 …the problems faced with getting small molecules to bind to these targets have been addressed, making sotorasib the first KRAS inhibitor to be approved in 2021. Now, candidates like divarasib… February 4, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 23 Mar 2023 OncoC4 and BioNTech partner in the commercialization of cancer drug candidate German biopharma BioNTech has closed a licensing deal with the U.S.-based clinical-stage company OncoC4 for the development and commercialization of the latter’s lead candidate ONC-392, for the treatment of cancer…. March 23, 2023 - 2 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Aug 2024 Seven companies transforming the biotech industry in Italy …Among them is a vaccine for malaria, which has received significant attention and funding, including $12.2 million from the EU Malaria Fund. Another prominent candidate is MAbCo19, a monoclonal antibody… August 22, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 19 Mar 2025 Breast cancer treatments heat up: Five therapies poised to transform patient outcomes …in 2023, in which BioNTech paid $55 million upfront for the rights to the candidate outside of greater China. The candidate in question is a bispecific antibody called BNT327 that… March 19, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Mar 2025 Seven biotech companies keeping Taiwan dynamic in 2025 …to enter the U.S. market in over 15 years. OBI Pharma Technology: Antibody-drug conjugate (ADC) platform targeting TROP2 Lead candidate: OBI-992 Recent news: Received FDA orphan drug designation for OBI-992… March 5, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 26 Nov 2024 Seven miRNA-focused companies pioneering new therapies in 2024 …RNA (mRNA) molecules, leading to mRNA degradation or inhibition of protein translation. Several companies are advancing candidates relying on miRNAs in 2024. miRNAs have garnered significant attention due to their… November 26, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 14 Nov 2016 Ask the Biotech Recruiter: Time-Saving Tricks to Reel in a New Hire …never had to write one before. Conversely, an attractive CV could hide a candidate’s lack of experience or exaggerations. For instance, did the candidate lead a project or merely participate… November 14, 2016 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Expert Advice 14 Dec 2020 How to Hire and Retain Talent in the Biotech Industry …specific profiles in the market, but as technology evolved candidates also had to evolve and develop new skills.” In addition, the number of qualified candidates for life sciences positions has… December 14, 2020 - 7 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email